Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of California, Davis
Medical University of South Carolina
National Institutes of Health Clinical Center (CC)
Celgene
Celgene
Celgene